PATH-29. CLINICAL SIGNIFICANCE OF TEMOZOLOMIDE-INDUCED SOMATIC HYPERMUTATION IN INITIALLY LOW-GRADE IDH-MUTANT DIFFUSE GLIOMAS
Yao Yu,Stephanie Hilz,Matthew Grimmer,David Solomon,Serah Choi,Michael Wahl,Tali Mazor,Chibo Hong,Anny Shai,Joanna J Phillips,Javier Villanueva-Meyer,Michael McDermott,Daphne Haas-Kogan,Jennie Taylor,Nicholas Butowski,Jennifer Clarke,Mitchel Berger,Annette Molinaro,Susan Chang,Joseph Costello,Nancy Ann Oberheim Bush Neuro-oncology（2018）
AI 理解论文
溯源树
样例
